Chronic hypertension other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) (/* Summary of Recommendations on The Search for Asymptomatic Organ Damage (DO NOT EDIT){{cite journal| author=Authors/Task Force Members. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A et al.| title=2013 ESH/ESC Guidelines for the management of...) |
Rim Halaby (talk | contribs) (/* 2013 ESH/ESC Guidelines For The Management of Arterial Hypertension (DO NOT EDIT){{cite journal| author=Authors/Task Force Members. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A et al.| title=2013 ESH/ESC Guidelines for the management of ar...) |
||
Line 31: | Line 31: | ||
|- | |- | ||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1. '''Examination of the [[retina]] should be considered in difficult to control or resistant hypertensive patients to detect [[hemorrhages]], exudates, and [[papilledema]], which are associated with increased CV risk. ''([[EHS ESC guidelines classification scheme#Level of Evidence|''Level of Evidence: C'']])''<nowiki>"</nowiki> | | bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1. '''Examination of the [[retina]] should be considered in difficult to control or resistant hypertensive patients to detect [[hemorrhages]], exudates, and [[papilledema]], which are associated with increased CV risk. ''([[EHS ESC guidelines classification scheme#Level of Evidence|''Level of Evidence: C'']])''<nowiki>"</nowiki> | ||
|} | |||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[EHS ESC guidelines classification scheme#Classification of Recommendations|Class IIb]] | |||
|- | |||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1. '''In hypertensive patients with cognitive decline, brain [[magnetic resonance imaging]] or [[computed tomography]] may be considered for detecting silent brain [[infarctions]], lacunar infarctions, microbleeds, and white matter lesions. ''([[EHS ESC guidelines classification scheme#Level of Evidence|''Level of Evidence: C'']])''<nowiki>"</nowiki> | |||
|} | |} | ||
Revision as of 01:48, 25 July 2013
Hypertension Main page |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
2013 ESH/ESC Guidelines For The Management of Arterial Hypertension (DO NOT EDIT)[1]
Summary of Recommendations on The Search for Asymptomatic Cardiovascular Disease (DO NOT EDIT)[1]
"1. Whenever history suggests myocardial ischaemia, a stress ECG test is recommended, and, if positive or ambiguous, an imaging stress test (stress echocardiography, stress cardiac magnetic resonance or nuclear scintigraphy) is recommended. (Level of Evidence: C)" |
Class IIa |
"1. Ultrasound scanning of carotid arteries should be considered to detect vascular hypertrophy or asymptomatic atherosclerosis, particularly in the elderly. (Level of Evidence: B)" |
"2. Carotid–femoral PWV should be considered to detect large artery stiffening. (Level of Evidence: B)" |
"3. Ankle–brachial index should be considered to detect PAD. (Level of Evidence: B)" |
Summary of Recommendations on The Search for Asymptomatic Organ Damage (DO NOT EDIT)[1]
Class IIa |
"1. Examination of the retina should be considered in difficult to control or resistant hypertensive patients to detect hemorrhages, exudates, and papilledema, which are associated with increased CV risk. (Level of Evidence: C)" |
Class IIb |
"1. In hypertensive patients with cognitive decline, brain magnetic resonance imaging or computed tomography may be considered for detecting silent brain infarctions, lacunar infarctions, microbleeds, and white matter lesions. (Level of Evidence: C)" |
Class III |
"1. Examination of the retina is not recommended in mild-to-moderate hypertensive patients without diabetes, except in young patients. (Level of Evidence: C)" |
References
- ↑ 1.0 1.1 1.2 Authors/Task Force Members. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A; et al. (2013). "2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)". Eur Heart J. 34 (28): 2159–219. doi:10.1093/eurheartj/eht151. PMID 23771844.